2023 - Research.com Medicine in Switzerland Leader Award
Internal medicine is frequently linked to Logistic regression in his study. His Internal medicine research extends to Logistic regression, which is thematically connected. His work often combines Pathology and Cardiology studies. In his works, he undertakes multidisciplinary study on Cardiology and Pathology. His Disease study frequently draws connections to other fields, such as Parkinsonism. Parkinsonism is closely attributed to Disease in his work. His research ties Fatty streak and Lesion together. His research on Fatty streak frequently links to adjacent areas such as Lesion. His research on Hyperintensity frequently connects to adjacent areas such as Radiology.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
High-density lipoprotein cholesterol as a predictor of coronary heart disease risk. The PROCAM experience and pathophysiological implications for reverse cholesterol transport
Gerd Assmann;Helmut Schulte;Arnold von Eckardstein;Yadong Huang.
Androgens and Coronary Artery Disease
Fredrick C. W. Wu;Arnold von Eckardstein.
Endocrine Reviews (2003)
Genome-wide association analyses identify 18 new loci associated with serum urate concentrations
Anna Köttgen;Anna Köttgen;Eva Albrecht;Alexander Teumer;Veronique Vitart.
Nature Genetics (2013)
Mechanisms underlying adverse effects of HDL on eNOS-activating pathways in patients with coronary artery disease
Christian Besler;Kathrin Heinrich;Lucia Rohrer;Carola Doerries.
Journal of Clinical Investigation (2011)
Fasting is not routinely required for determination of a lipid profile: Clinical and laboratory implications including flagging at desirable concentration cut-points - A joint consensus statement from the European Atherosclerosis Society and European Federation of Clinical Chemistry and Laboratory Medicine
Børge G. Nordestgaard;Anne Langsted;Samia Mora;Genovefa Kolovou.
European Heart Journal (2016)
Endothelial-Vasoprotective Effects of High-Density Lipoprotein Are Impaired in Patients With Type 2 Diabetes Mellitus but Are Improved After Extended-Release Niacin Therapy
Sajoscha A. Sorrentino;Christian Besler;Lucia Rohrer;Martin Meyer.
Altered Activation of Endothelial Anti- and Proapoptotic Pathways by High-Density Lipoprotein from Patients with Coronary Artery Disease Role of High-Density Lipoprotein–Proteome Remodeling
Meliana Riwanto;Lucia Rohrer;Bernd Roschitzki;Christian Besler.
The emergence of triglycerides as a significant independent risk factor in coronary artery disease
G Assmann;H Schulte;H Funke;A von Eckardstein.
European Heart Journal (1998)
Inflammatory Markers at the Site of Ruptured Plaque in Acute Myocardial Infarction Locally Increased Interleukin-6 and Serum Amyloid A but Decreased C-Reactive Protein
Willibald Maier;Lukas A. Altwegg;Roberto Corti.
High-Density Lipoprotein Vascular Protective Effects, Dysfunction, and Potential as Therapeutic Target
Thomas F. Lüscher;Ulf Landmesser;Arnold von Eckardstein;Alan M. Fogelman.
Circulation Research (2014)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: